Starpharma’s DEP Delivery Technology Edge Explained In AstraZeneca’s Bcl-2/Bcl-xL Drug AZD0466 (OTCMKTS:SPHRF)
June 25th, 2020 | 🕒
iSpeech A lot of small molecule anticancer drugs have significant downsides due to poor solubility (requiring detergent additives that are
Gloss